HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 3 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilience RELATED ARTICLES Strategy 11 ways to make your time feel less rushed during a busy week Strategy The racetrack is getting a long overdue makeover Strategy How ‘Masters of the Universe’ emerged from the biggest IP blunder in movie history Strategy What to expect from Apple at WWDC 26 on Monday: Siri AI, iOS 27, refined Liquid Glass, John Ternus, and more Must Read Dell sharpens data protection strategy as AI reshapes cyber resilience Tech Housing demand stays positive with mortgage rates near 2026 highs Real Estate 11 ways to make your time feel less rushed during a busy week Strategy The racetrack is getting a long overdue makeover Strategy How ‘Masters of the Universe’ emerged from the biggest IP blunder in movie history Strategy